DexCom (DXCM) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
DexCom (DXCM) PT Raised to $73 at Wedbush
February 26, 2015 7:00 AM ESTWedbush analyst Tao Levy reiterated an Outperform rating and boosted its price target on DexCom (NASDAQ: DXCM) to $73.00 (from $70.00) following Q4 results which were surprising profitably with several upcoming catalysts.
Levy commented, "With DexCom already having preannounced 4Q results, it... More
